Washington, Sept 28 : An experimental drug called pertuzumab may help prolong the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor has said.

Dr. Sharmila Makhija, an associate professor in the Division of Gynecologic Oncology at the university, said that Phase II clinical trial data showed that pertuzumab added weeks to the lives of Stage III ovarian cancer patients, whose disease had returned after treatment with the existing chemotherapy regimens.

Washington, September 28 : Gorging on those French fries and hamburgers may not be a good idea anymore, with a new study showing that fatty foods cooked at high temperatures may cause a significant dysfunction in blood vessel dilation that can lead to heart disease.

Winnipeg: Canadian veterinary functionaries stated that they have detected the H7N3 strain of avian influenza on a Saskatchewan farm, but pointed out the virus was not the lethal strain, which researchers fear could result in the next flu plague.